Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators
Dungan, Kathleen M., Bardtrum, Lars, Christiansen, Erik, Eliasson, Johanna, Mellbin, Linda, Woo, Vincent C., Vilsbøll, Tina
Published in Diabetes therapy (01.08.2023)
Published in Diabetes therapy (01.08.2023)
Get full text
Journal Article
Greater Combined Reductions of HbA 1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators
Dungan, Kathleen M, Bardtrum, Lars, Christiansen, Erik, Eliasson, Johanna, Mellbin, Linda, Woo, Vincent C, Vilsbøll, Tina
Published in Diabetes therapy (01.08.2023)
Published in Diabetes therapy (01.08.2023)
Get full text
Journal Article
Glycaemic and body weight responses to oral semaglutide in the PIONEER trial programme
Mellbin, L, Christiansen, E, Hertz, CL, Nielsen, MA, Vilsboll, T, Woo, VC, Dungan, KM
Published in DIABETOLOGIA (2020)
Get full text
Published in DIABETOLOGIA (2020)
Conference Proceeding